Browse Discover Builder Rankings Pricing

Private market intelligence for investors, founders, and sales teams.

Product

Browse
Discover
List Builder
Rankings
Pricing

Developers

API Reference
API Keys

Company

About
Terms
Privacy
Contact

© 2026 Indexed.vc. All rights reserved.

Interface Biosciences: Company Profile & Funding | Indexed.vc

Interface Biosciences

Interface Bio

Artificial Intelligence

Business Model: B2B

Website: interface.bio

About

AI-enabled metabolomics-based drug discovery platform using microbiome natural products to treat inflammatory diseases.

Similar Companies

Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.

Tianjin, China5001–10000Healthcare, Biotech

Private Equity·$2.3B·Feb 2020

Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...

Waltham, United States1001–5000Artificial Intelligence, Healthcare

Extension Round·$3.5B·Aug 2024

Isomorphic Labs

AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...

London, United Kingdom201–500Artificial Intelligence, Biotech

Venture Unknown·$3.2B·May 2026

South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...

Chuncheon, South Korea201–500Aesthetics, Biotech

Private Equity·$2.3B·Aug 2021

Global full-service clinical research organization (CRO) and scientific advisory partner for biot...

Sydney, Australia1001–5000Biotech, Healthcare

Growth Equity·$1.9B·Mar 2025

OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...

San Francisco, United States5001–10000Artificial Intelligence, Generative AI

Series G Plus·$593.2B·Mar 2026